These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 27565917)

  • 1. Quality of life, symptom status and physical performance in patients with advanced non-small cell lung cancer undergoing chemotherapy: an exploratory analysis of secondary data.
    Shallwani SM; Simmonds MJ; Kasymjanova G; Spahija J
    Lung Cancer; 2016 Sep; 99():69-75. PubMed ID: 27565917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
    Sztankay M; Giesinger JM; Zabernigg A; Krempler E; Pall G; Hilbe W; Burghuber O; Hochmair M; Rumpold G; Doering S; Holzner B
    BMC Cancer; 2017 Aug; 17(1):565. PubMed ID: 28835219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort study.
    von Verschuer U; Schnell R; Tessen HW; Eggert J; Binninger A; Spring L; Jänicke M; Marschner N;
    Lung Cancer; 2017 Oct; 112():216-224. PubMed ID: 28916198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer.
    Mohan A; Singh P; Kumar S; Mohan C; Pathak AK; Pandey RM; Guleria R
    Asian Pac J Cancer Prev; 2008; 9(4):557-62. PubMed ID: 19256738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Brain Metastasis on Patient-Reported Outcomes in Advanced NSCLC Treated in Real-World Community Oncology Settings.
    Walker MS; Wong W; Ravelo A; Miller PJE; Schwartzberg LS
    Clin Lung Cancer; 2018 Mar; 19(2):139-147. PubMed ID: 29103883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom experiences and health-related quality of life among non-small cell lung cancer patients participating in clinical trials.
    Lee K; Oh EG; Kim S; Kim SW
    J Clin Nurs; 2019 Jun; 28(11-12):2111-2123. PubMed ID: 30667122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.
    Fiteni F; Vernerey D; Bonnetain F; Vaylet F; Sennélart H; Trédaniel J; Moro-Sibilot D; Herman D; Laizé H; Masson P; Derollez M; Clément-Duchêne C; Milleron B; Morin F; Zalcman G; Quoix E; Westeel V
    Eur J Cancer; 2016 Jan; 52():120-8. PubMed ID: 26682871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of quality of life in patients with advanced non-small cell lung carcinoma treated with a combination of carboplatin and paclitaxel.
    Avelino CU; Cardoso RM; Aguiar SS; Silva MJ
    J Bras Pneumol; 2015; 41(2):133-42. PubMed ID: 25972967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer.
    van der Kloot WA; Uchida Y; Inoue K; Kobayashi K; Yamaoka K; Nortier HW; Kaptein AA
    Chin Clin Oncol; 2016 Feb; 5(1):3. PubMed ID: 26932427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptom Assessment for Patients with Non-small Cell Lung Cancer Scheduled for Chemotherapy.
    Silvoniemi M; Vasankari T; Löyttyniemi E; Valtonen M; Salminen E
    Anticancer Res; 2016 Aug; 36(8):4123-8. PubMed ID: 27466520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in long-term survivors of unresectable locally advanced non-small cell lung cancer.
    Ran J; Wang J; Bi N; Jiang W; Zhou Z; Hui Z; Liang J; Feng Q; Wang L
    Radiat Oncol; 2017 Dec; 12(1):195. PubMed ID: 29197373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany.
    Iyer S; Taylor-Stokes G; Roughley A
    Lung Cancer; 2013 Aug; 81(2):288-93. PubMed ID: 23561304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer.
    Lal R; Hillerdal GN; Shah RN; Crosse B; Thompson J; Nicolson M; Vikström A; Potter VA; Visseren-Grul C; Lorenzo M; D'yachkova Y; Bourayou N; Summers YJ
    Lung Cancer; 2015 Aug; 89(2):154-60. PubMed ID: 26101013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deterioration in physical activity and function differs according to treatment type in non-small cell lung cancer - future directions for physiotherapy management.
    Granger CL; Parry SM; Edbrooke L; Denehy L
    Physiotherapy; 2016 Sep; 102(3):256-63. PubMed ID: 26597694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of a Multidimensional Exercise Intervention on Physical and Functional Capacity, Anxiety, and Depression in Patients With Advanced-Stage Lung Cancer Undergoing Chemotherapy.
    Quist M; Adamsen L; Rørth M; Laursen JH; Christensen KB; Langer SW
    Integr Cancer Ther; 2015 Jul; 14(4):341-9. PubMed ID: 25800229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in patients with advanced nonsquamous non-small-cell lung cancer receiving bevacizumab or bevacizumab-plus-pemetrexed maintenance therapy in AVAPERL (MO22089).
    Rittmeyer A; Gorbunova V; Vikström A; Scherpereel A; Kim JH; Ahn MJ; Chella A; Chouaid C; Campbell AK; Barlesi F
    J Thorac Oncol; 2013 Nov; 8(11):1409-16. PubMed ID: 24077452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of depressive symptoms, personality traits, and sociodemographic factors with health-related quality of life and quality of life in patients with advanced-stage lung cancer: an observational multi-center cohort study.
    de Mol M; Visser S; Aerts J; Lodder P; van Walree N; Belderbos H; den Oudsten B
    BMC Cancer; 2020 May; 20(1):431. PubMed ID: 32423432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing functional status and the survival benefit of chemotherapy for advanced non-small cell lung cancer using administrative claims data.
    Feliciano J; Gardner L; Hendrick F; Edelman MJ; Davidoff A
    Lung Cancer; 2015 Jan; 87(1):59-64. PubMed ID: 25443272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1).
    Hirsh V; Cadranel J; Cong XJ; Fairclough D; Finnern HW; Lorence RM; Miller VA; Palmer M; Yang JC
    J Thorac Oncol; 2013 Feb; 8(2):229-37. PubMed ID: 23328549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life in lung cancer patients in Serbia: correlation with socio-economic and clinical parameters.
    Maric D; Jovanovic D; Golubicic I; Dimic S; Pekmezovic T
    Eur J Cancer Care (Engl); 2010 Sep; 19(5):594-602. PubMed ID: 20030692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.